Christopher Ryan Sullivan

Chief Financial Officer, Avalo Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$3.7M

Companies

Latest trade

Sep 16, 2026

Companies

Avalo Therapeutics, Inc.Chief Financial Officer −$3.7M

Trades

AVTX Sold 12,394 shares at $16.33 · planned $0.2M Sep 16

AVTX Sold 10,185 shares at $17.62 · planned $0.2M Sep 10

AVTX Sold 31,031 shares at $20.05 · planned $0.6M Aug 18

AVTX Sold 41,694 shares at $19.86 · planned $0.8M Aug 17

AVTX Sold 18,606 shares at $24.12 · planned $0.4M May 7

AVTX Sold 47,000 shares at $20.18 · planned $0.9M May 6

AVTX Sold 8,457 shares at $13.23 · planned $0.1M Apr 30

AVTX Sold 8,458 shares at $13.09 · planned $0.1M Apr 29

AVTX Sold 7,980 shares at $17.14 · planned $0.1M Apr 2

AVTX Sold 7,979 shares at $16.77 · planned $0.1M Apr 1

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.